00618nas a2200181   4500000000100000008004100001100001200042700001300054700001500067700001500082700001900097700001200116700001500128700001400143700001300157245025200170022001400422       2021                            d1 aJ. Webb1 aJ. Mount1 aL. von Arx1 aJ. Rachman1 aD. Spanopoulos1 aR. Wood1 aT. Tritton1 aO. Massey1 aI. Idris00aCardiovascular risk profiles: A cross-sectional study evaluating the generalisability of the glucagon-like peptide-1 receptor agonist cardiovascular outcome trials Rewind, Leader and Sustain-6 to the real-world type 2 diabetes population in the UK  a1462-8902